@article{874e81c17cbc4c99bfc9a22b1b72c2b1,
title = "Targeted Intraoperative Radiotherapy for Early Breast Cancer",
author = "Gerd Fastner and Leonardi, {Maria Cristina} and Poortmans, {Philip M.}",
note = "Funding Information: reported receiving grant funding and personal fees from Merck. Dr Simone reported receiving an honorarium from Varian Medical Systems. Dr Malhotra reported receiving research funding from Bristol-Myers Squibb, BeyondSpring, Celldex, and Biohaven and personal fees from AstraZeneca. Funding Information: Conflict of Interest Disclosures: Dr Vaidya reported receiving grants, honoraria, and travel fees from Carl Zeiss. Drs Vaidya and Bulsara reported receiving grant funding from the Health Technology Assessment Programme of the National Institute for Health Research, UK, for TARGIT trials. Dr Baum was on the scientific advisory board of Carl Zeiss and was paid monthly consultancy fees briefly before 2010. Carl Zeiss sponsors some travel and accommodation for meetings related to TARGIT trials for all authors. Copyright: Copyright 2020 Elsevier B.V., All rights reserved.",
year = "2020",
month = oct,
doi = "10.1001/jamaoncol.2020.2719",
language = "English",
volume = "6",
pages = "1636--1637",
journal = "JAMA oncology",
issn = "2374-2437",
publisher = "American Medical Association",
number = "10",
}